Multidrug-resistant pulmonary tuberculosis: surgical challenges.
Multidrug-resistant tuberculosis (MDR-TB) continues to be a significant public health problem worldwide. The treatment of MDR-TB consists mainly of chemotherapy. However, surgery has been reported to be an effective adjunctive therapy in selected cases. This article discusses the scope of the problem of MDR-TB and the most accepted modern standard therapy. The indications for surgical intervention as well as an analysis of the results of this therapy are also discussed.
Section of General Thoracic Surgery, Division of Cardiothoracic Surgery, Department of Surgery, University of Colorado School of Medicine, 12631 East 17th Avenue, MSC310, Aurora, CO 80045, USA. Michael.Weyant@ucdenver.edu
Michael J
MJ
Weyant
John D
JD
Mitchell
D054908:Extensively Drug-Resistant Tuberculosis / Q000601:surgery; D006801:Humans; D018088:Tuberculosis, Multidrug-Resistant / Q000150:complications / Q000601:surgery*; D014397:Tuberculosis, Pulmonary / Q000601:surgery*